Titlebook: Mediastinal Tumors; Update 1995 Douglas E. Wood (Head),Charles R. Thomas (Fellow, Book 1995 Springer-Verlag Berlin Heidelberg 1995 Onkolog

Cyclone

書目名稱Mediastinal Tumors影響因子(影響力)




書目名稱Mediastinal Tumors影響因子(影響力)學(xué)科排名




書目名稱Mediastinal Tumors網(wǎng)絡(luò)公開度




書目名稱Mediastinal Tumors網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Mediastinal Tumors被引頻次




書目名稱Mediastinal Tumors被引頻次學(xué)科排名




書目名稱Mediastinal Tumors年度引用




書目名稱Mediastinal Tumors年度引用學(xué)科排名




書目名稱Mediastinal Tumors讀者反饋




書目名稱Mediastinal Tumors讀者反饋學(xué)科排名

outer-ear

擁護(hù)

Earle W. Wilkins Jr. M.D.ust develop a set of new management practices to be able to invest in multiple strategic directions. They are responsible for giving clients a remarkable experience and for creating social relationship capital based upon an open innovation culture. Open Innovation in the Financial Services provides

喚醒

Wui-Jin Koh M.D.,Patrick J. Loehrer Sr. M.D.,Charles R. Thomas Jr. M.D.uture and found what strategies, structures, and capabilities firms may exhibit in response to developments in the business environment. Traditional approaches to strategy are proving to be inadequate to deal with these changes. Those firms that want to survive and succeed in a hypercompetitive glob

NOVA

Ornithologist

HAWK

inculpate

Primary Mediastinal Seminoma,t explain the finding of mediastinal seminoma in women. In 1951, F. proposed a theory supporting the existence of primary extragonadal germ cell tumors which has become generally accepted [3]. The theory states that displaced primordial germ cells, which are located along the midline, are the origin

hazard

Mediastinal Paragangliomas,n the mediastinum. Embryology, diagnosis, and management will be considered. Neurogenic tumors are the most common primary mediastinal tumor, accounting for 21% of mediastinal tumors in the adult population. The majority of these are neurilemmomas (40%–60%), ganglioneuromas and neuroblastomas (33%),

解凍

The Role of Three-Dimensional Conformal Radiotherapy in the Treatment of Mediastinal Tumors,th its routine use will ultimately result in its widespread adoption. To test the hypothesis that this technology will result in improved local control and possibly survival, phase I/II dose escalation studies sponsored by the Radiation Therapy Oncology Group (RTOG) are underway. In this review we d